Announced Mon, 11 May · 16:53 IST

Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.6%1-day move
₹31.69
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.6-5.9-8.5-6.9-7.5-2.5-8.5-10.4-10.1
Up moveDown movePending
AI summary

Prism Medico and Pharmacy Limited held a Board meeting on May 11, 2026, which lasted 30 minutes. The Board approved the appointment of Mr. Harpreet Singh from M/s. S Harpreet and Associates, Chartered Accountants, as the internal auditor for the financial year 2025-2026. This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The appointment is a routine corporate governance action to ensure independent internal audit coverage of company operations and financials.

Likely market impact

The appointment of an internal auditor is standard governance practice and has no direct impact on the stock price or shareholder value in the near term. It reflects routine compliance with listing requirements.